Norifumi Harimoto

6.8k total citations
275 papers, 5.2k citations indexed

About

Norifumi Harimoto is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Norifumi Harimoto has authored 275 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Surgery, 126 papers in Hepatology and 82 papers in Oncology. Recurrent topics in Norifumi Harimoto's work include Hepatocellular Carcinoma Treatment and Prognosis (77 papers), Liver Disease Diagnosis and Treatment (62 papers) and Liver Disease and Transplantation (55 papers). Norifumi Harimoto is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (77 papers), Liver Disease Diagnosis and Treatment (62 papers) and Liver Disease and Transplantation (55 papers). Norifumi Harimoto collaborates with scholars based in Japan, United States and Israel. Norifumi Harimoto's co-authors include Ken Shirabe, Yoshihiko Maehara, Tomoharu Yoshizumi, Toru Ikegami, Shinji Itoh, Yo‐ichi Yamashita, Yuji Soejima, Hideaki Uchiyama, Tetsuo Ikeda and Eiji Tsujita and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Surgery.

In The Last Decade

Norifumi Harimoto

254 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norifumi Harimoto Japan	36	2.2k	2.1k	1.6k	1.4k	1.1k	275	5.2k
Toshimi Kaido Japan	39	3.2k 1.5×	3.3k 1.6×	1.2k 0.7×	1.8k 1.3×	2.0k 1.9×	265	6.5k
Dietmar Tamandl Austria	34	1.3k 0.6×	1.4k 0.7×	1.8k 1.1×	586 0.4×	496 0.5×	110	4.0k
Georgios Antonios Margonis United States	35	1.6k 0.7×	1.5k 0.7×	2.0k 1.3×	481 0.3×	430 0.4×	124	3.5k
Hideaki Uchiyama Japan	39	3.8k 1.7×	3.5k 1.7×	886 0.6×	1.9k 1.3×	432 0.4×	238	5.8k
Akira Chikamoto Japan	34	1.1k 0.5×	1.5k 0.7×	2.0k 1.2×	939 0.7×	274 0.2×	226	4.0k
Thomas Aparicio France	40	370 0.2×	1.8k 0.9×	3.6k 2.3×	1.5k 1.0×	519 0.5×	254	6.5k
Kazunari Sasaki United States	31	1.9k 0.9×	1.5k 0.7×	1.3k 0.8×	615 0.4×	278 0.3×	211	3.3k
Derek Manas United Kingdom	39	1.7k 0.8×	2.4k 1.1×	1.2k 0.8×	1.2k 0.9×	187 0.2×	199	5.1k
Pia Österlund Finland	27	626 0.3×	492 0.2×	3.0k 1.9×	961 0.7×	301 0.3×	96	4.2k
Takashi Matsumata Japan	39	3.0k 1.3×	2.2k 1.1×	1.4k 0.9×	1.5k 1.1×	225 0.2×	192	5.2k

Countries citing papers authored by Norifumi Harimoto

Since Specialization

Citations

This map shows the geographic impact of Norifumi Harimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norifumi Harimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norifumi Harimoto more than expected).

Fields of papers citing papers by Norifumi Harimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norifumi Harimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norifumi Harimoto. The network helps show where Norifumi Harimoto may publish in the future.

Co-authorship network of co-authors of Norifumi Harimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Norifumi Harimoto. A scholar is included among the top collaborators of Norifumi Harimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norifumi Harimoto. Norifumi Harimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamanaka, Takahiro, Kenichiro Araki, Takehiko Yokobori, et al.. (2024). Potential of Mac‐2‐binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer Science. 115(4). 1241–1249. 7 indexed citations

Tsukagoshi, Mariko, Kenichiro Araki, Takamichi Igarashi, et al.. (2024). Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma. Nutrients. 16(7). 940–940. 9 indexed citations

Hoshino, Kouki, Seshiru Nakazawa, Takehiko Yokobori, et al.. (2024). RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation. Scientific Reports. 14(1). 346–346. 1 indexed citations

Tsukagoshi, Mariko, Akira Watanabe, Kenichiro Araki, et al.. (2023). Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer. Annals of Gastroenterological Surgery. 7(5). 784–792. 7 indexed citations

Ishii, Norihiro, Norifumi Harimoto, Ryo Muranushi, et al.. (2023). The impact of lymphangiograpy on chyle leakage treatment duration after pancreatic surgery. Surgery Today. 54(6). 651–657. 2 indexed citations

Igarashi, Takamichi, Norifumi Harimoto, Ryo Muranushi, et al.. (2021). Does intraoperative and postoperative analgesia cause bile leakage after hepatectomy?. Surgery Today. 52(4). 690–696. 2 indexed citations

Yamanaka, Takahiro, Norifumi Harimoto, Takehiko Yokobori, et al.. (2021). Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein–coupled Receptor 68. Molecular Cancer Therapeutics. 20(6). 1019–1028. 22 indexed citations

Hatanaka, Takeshi, Satoru Kakizaki, Takashi Ueno, et al.. (2021). Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative Study. Oncology. 99(10). 641–651. 5 indexed citations

Hatanaka, Takeshi, Atsushi Naganuma, Yosuke Arai, et al.. (2020). The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study. Oncology. 99(4). 203–214. 9 indexed citations

10.

Hatanaka, Takeshi, Satoru Kakizaki, Takashi Ueno, et al.. (2020). Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment. Cancers. 12(10). 2906–2906. 14 indexed citations

11.

Makiguchi, Takaya, Takahiro Yamaguchi, Hidenori Nakamura, et al.. (2020). Evaluation of overall and disease‐free survival in patients with free flaps for oral cancer resection. Microsurgery. 40(8). 859–867. 7 indexed citations

12.

Makiguchi, Takaya, Takahiro Yamaguchi, Hidenori Nakamura, et al.. (2020). Impact of skeletal muscle mass on postoperative delirium in patients undergoing free flap repair after oral cancer resection. Journal of Plastic Surgery and Hand Surgery. 54(3). 161–166. 25 indexed citations

13.

Hatanaka, Takeshi, Satoru Kakizaki, Hiroki Tojima, et al.. (2019). Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. Hepatology Research. 50(3). 382–395. 23 indexed citations

14.

Itoh, Shinji, Toru Ikegami, Tomoharu Yoshizumi, et al.. (2015). Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma.. PubMed. 35(4). 2475–6. 18 indexed citations

15.

Kawanaka, Hirofumi, Tomohiko Akahoshi, Shinji Itoh, et al.. (2014). Optimizing Risk Stratification in Portal Vein Thrombosis after Splenectomy and its Primary Prophylaxis with Antithrombin III Concentrates and Danaparoid Sodium in Liver Cirrhosis with Portal Hypertension. Journal of the American College of Surgeons. 219(5). 865–874. 40 indexed citations

16.

Ikegami, Toru, Ken Shirabe, Yuji Soejima, et al.. (2013). Antiviral treatment after living donor liver transplantation for hepatitis C. 62–63.

17.

Abe, Tomoyuki, Ken Shirabe, Norifumi Harimoto, et al.. (2009). Two cases of hepatocellular carcinoma with erythrocytosis. Kanzo. 50(9). 540–546.

18.

Sakaguchi, Yoshihisa, Yasushi Toh, Yoshiro Aoki, et al.. (2008). Clinical Characteristics of Gastric Cancer with Metastasis to the Lymph Node along the Superior Mesenteric Vein (14v). Digestive Surgery. 25(5). 351–358. 26 indexed citations

19.

Maeda, Takashi, Mitsuo Shimada, Norifumi Harimoto, et al.. (2005). Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma.. PubMed. 52(61). 187–90. 22 indexed citations

20.

Tanaka, Shinji, K Sugimachi, Shin‐ichiro Maehara, et al.. (2002). Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma. Surgery. 131(1). S142–S147. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact